The outlook change reflects the rating agency’s opinion margin challenges, declining liquidity related to Medicaid cuts and increasing bad debt are expected to continue to suppress the health system’s performance and weaken leverage metrics.
Moody’s Investors Service also affirmed the “A2” rating on the health system’s bonds, affecting $385 million of outstanding debt. The ratings affirmation is based on a number of factors, including the health system’s strong market position and modest debt structure.
More articles on healthcare finance:
Moody’s revises Tampa Bay General Hospital’s outlook to stable
UF Health Shands Hospital adopts new policy to minimize debt
Oregon Advanced Imaging selects McKesson for RCM
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
